Clinical Trial Update: Effect of Lithium in Patients With Autism Spectrum Disorder and Phelan-McDermid Syndrome (SHANK3 Haploinsufficiency) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lithium for autism spectrum disorder, including individuals with Phelan-McDermid syndrome due to SHANK3 haploinsufficiency; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Phelan-mcdermid Syndrome

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Autism Spectrum Disorder | Phase 3 | Status: COMPLETED